SOLENO THERAPEUT. DL-001 (6XC) — Cash Flow Reinvestment Rate
SOLENO THERAPEUT. DL-001 (6XC) has a Cash Flow Reinvestment Rate of 2.57x as of December 2025, reinvesting €125.36 Million (capex €58.00K plus investments €-125.30 Million) from operating cash flow of €48.70 Million. Check cash flow quality index of SOLENO THERAPEUT. DL-001 to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
SOLENO THERAPEUT. DL-001 Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for SOLENO THERAPEUT. DL-001 across 1 annual periods. Explore 6XC strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for SOLENO THERAPEUT. DL-001 (2025–2025)
Year-by-year capital reinvestment analysis for SOLENO THERAPEUT. DL-001. For live market cap and broader valuation context, see 6XC stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 4.31x | €201.78 Million | €46.80 Million | €73.00K | — |